Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy, and Research), and End-User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)
No. of Pages:112
Report Code:
TIPRE00028652
Category:
Life Sciences
South and Central America Circulating Tumor Cell (CTC) Diagnostics Market
The South & Central America circulating tumor cell (CTC) diagnostics market is expected to reach US$ 214.0 million by 2028 from US$ 116.9 million in 2021. The market is estimated to grow at a CAGR of 9.0% from 2021 to 2028.
Health systems across the region are witnessing a substantial increase in the prevalence of cancer. Thus, the increased prevalence of cancer across South & Central America is propelling the demand for circulating tumor cell diagnostics. The analysis and detection of circulating tumor cells assist in early patient diagnosis, and the prognosis helps determine accurate treatment for these patient. The CTC diagnostics products to detect various types of cancers, including prostate cancer, breast cancer, colorectal cancer, kidney cancer, lymphomas, lung cancer, and melanoma. There has been a high demand for CTC diagnostics in recent years due the reliability and accuracy of this technique in identifying the risk of various cancers and monitoring different cancer treatments.
Brazil, Argentina, Uruguay, Chile, Peru, and Colombia were hit by the second wave of corona infection. Brazil has registered the majority of deaths due to this disease in South and Central America. Moreover, COVID-19 impacted the number of patients undergoing cancer diagnosis, screening, and treatment. The havoc created by COVID-19 compelled majority of pharmaceutical and biotechnology companies to shift their focus on the development of novel therapies and diagnostics for this disease. Moreover, continuous strain due to the COVID-19 outbreak impacted supply chains, company operations, and distribution systems, including their R&D abilities, and novel product launches and services. Thus, the COVID-19 pandemic hampered the circulating tumor cell (CTC) diagnostics market in SCAM during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the circulating tumor cell (CTC) diagnostics market. The South & Central America circulating tumor cell (CTC) diagnostics market is expected to grow at a good CAGR during the forecast period.
South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Segmentation
By Technology
CTC detection and Enrichment Method
CTC Direct Detection Methods
CTC Analysis
By Application
Clinical/Liquid Biopsy
Risk Assessment
Screening and Monitoring
Research
Cancer Stem Cell and Tumorigenesis Research
Drug/Therapy Development
By End-User
Hospitals and Clinics
Research and Academic Institutes
Diagnostic Centers
By Country
Brazil
Argentina
Rest of South & Central America
Companies Mentioned
Thermo Fisher Scientific Inc.
Stemcell Technologies Inc.
Qiagen
Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
Fluxion Bioscience
South and Central America Circulating Tumor Cell (CTC) Diagnostics Market Strategic Insights
Get more information on this report
South and Central America Circulating Tumor Cell (CTC) Diagnostics Market Segmentation Analysis
South and Central America Circulating Tumor Cell (CTC) Diagnostics Market Report Highlights
South and Central America Circulating Tumor Cell (CTC) Diagnostics Report Scope
Report Attribute
Details
Market size in 2021
US$ 116.9 Million
Market Size by 2028
US$ 214.0 Million
CAGR (2021 - 2028)
9.0%
Historical Data
2019-2020
Forecast period
2022-2028
Segments Covered
By Technology
CTC Detection and Enrichment Method
CTC Direct Detection Method
CTC Analysis
By Application
Clinical/Liquid Biopsy
Research
By End-User
Hospitals and Clinics
Research and Academic Institutes
Diagnostic Centers
Regions and Countries Covered
South and Central America
Brazil, Argentina, Rest of South and Central America
Market leaders and key company profiles
Thermo Fisher Scientific Inc.
Stemcell Technologies Inc.
Qiagen
Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
Fluxion Biosciences
Get more information on this report
South and Central America Circulating Tumor Cell (CTC) Diagnostics Market Country and Regional Insights
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - South and Central America Circulating Tumor Cell (CTC) Diagnostics Market
Thermo Fisher Scientific Inc.
Stemcell Technologies Inc.
Qiagen
Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
Fluxion Biosciences
Frequently Asked Questions
How big is the South and Central America Circulating Tumor Cell (CTC) Diagnostics Market?
The South and Central America Circulating Tumor Cell (CTC) Diagnostics Market is valued at US$ 116.9 Million in 2021, it is projected to reach US$ 214.0 Million by 2028.
What is the CAGR for South and Central America Circulating Tumor Cell (CTC) Diagnostics Market by (2021 - 2028)?
As per our report South and Central America Circulating Tumor Cell (CTC) Diagnostics Market, the market size is valued at US$ 116.9 Million in 2021, projecting it to reach US$ 214.0 Million by 2028. This translates to a CAGR of approximately 9.0% during the forecast period.
What segments are covered in this report?
The South and Central America Circulating Tumor Cell (CTC) Diagnostics Market report typically cover these key segments-
Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, CTC Analysis)
Application (Clinical/Liquid Biopsy, Research)
End-User (Hospitals and Clinics, Research and Academic Institutes, Diagnostic Centers)
What is the historic period, base year, and forecast period taken for South and Central America Circulating Tumor Cell (CTC) Diagnostics Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Circulating Tumor Cell (CTC) Diagnostics Market report:
Historic Period : 2019-2020
Base Year : 2021
Forecast Period : 2022-2028
Who are the major players in South and Central America Circulating Tumor Cell (CTC) Diagnostics Market?
The South and Central America Circulating Tumor Cell (CTC) Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Thermo Fisher Scientific Inc.
Stemcell Technologies Inc.
Qiagen
Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
Fluxion Biosciences
Who should buy this report?
The South and Central America Circulating Tumor Cell (CTC) Diagnostics Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the South and Central America Circulating Tumor Cell (CTC) Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For South and Central America Circulating Tumor Cell (CTC) Diagnostics Market
